Losartan, an angiotensin II type 1 receptor blocker, protects human islets from glucotoxicity through the phospholipase C pathway
暂无分享,去创建一个
J. Rieusset | D. Bosco | S. Ducreux | F. van Coppenolle | A. Madec | A. Mesnier | C. Thivolet | M. Chauvin | S. Dubois | G. Vial | K. Chikh | R. Cassel